Reports and Commentaries

Innogen Policy Briefs

Appropriate Governance of the Life Sciences Series (2008-2012)

Multinational Company Innovation Strategies
Joyce Tait

The Case for Smart Regulation
Joyce Tait, Joanna Chataway and David Wield

Regulating GM Crops: lessons for next generation technologies
Joyce Tait, Ann Bruce, Joanna Chataway, David Wield

Pharmaceutical Futures: Health biotechnology to 2030
Joyce Tait, Joanna Chataway and David Wield

Health Innovation for the world’s poor: Who are the players and what is the game?
Joanna Chataway, Rebecca Hanlin, Joyce Tait and David Wield

Where are Product Development Partnerships (PDPs) headed and how can THeSyS help them get there?
Joanna Chataway, Rebecca Hanlin, Julius Mugwagwa and Lois Muraguri

Interrogating the feasibility of cross-national cooperation in technology governance: the case of biosafety in southern Africa
Julius Mugwagwa

Smarter Regulation of Drug Development: FDA Orphan Products and Fast Track Programmes
Christopher-Paul Milne and Joyce Tait

Pros and Cons of the Precautionary Principle (PP): European Experience with the regulation of GM Crops
Joyce Tait and Joanna Chataway

Cross-national convergence of biosafety systems in Sub-Saharan Africa
Julius Mugwagwa

Governing Synthetic Biology
Joyce Tait

Innogen Working Papers

Economics and Public Health: A case for interdisciplinary cohesion in the time of Coronavirus NEW!

Pritika Rao and Smita Srinivas

Covid-19 Balancing the needs of public health and the economy  NEW!

Farah Huzair and Joyce Tait

Behavioural Responses to Pandemic Influenza: Contingency Planning and its Implementation in the UK (2009)

Joyce Tait and Ann Bruce

FINANCING AFRICAN LOCAL PHARMACEUTICAL PRODUCTION

Geoffrey Banda

THE EFFECT OF THE DYNAMICS OF KNOWLEDGE BASE COMPLEXITY ON SCHUMPETERIAN PATTERNS OF INNOVATION: THE UPSTREAM PETROLEUM INDUSTRY
Ali Maleki, Alessandro Rosiello and David Wield

PHARMACEUTICAL EVOLUTION: CLINICAL SELECTION VERSUS INTELLIGENT DESIGN
Jack W. Scannell

FOUR REASONS DRUGS ARE EXPENSIVE, OF WHICH TWO ARE FALSE
AN OPINION

Jack W. Scannell

IT’S NOT STI: IT’S ITS
THE ROLE OF SCIENCE, TECHNOLOGY AND INNOVATION (STI) IN AFRICA’S
DEVELOPMENT STRATEGY

Norman Clark and Andy Frost

THE IMAGINED HEALTH COMMUNITY: NARRATIVES OF SCOTTISH HEALTH AND
INDEPENDENCE

MicheIe Mastroeni, Elisabeth Barlow, James Mittra and David Wield

SCIENCE AND INDUSTRIAL DYNAMICS IN SCOTLAND

Omid Omidvar, Joyce Tait and David Wield

 

Innogen Reports

Report on the bibliometric indicators of innogen (2002-2010)
Ismael Rafols and Rodrigo Costas

Disciplinary portfolio of Innogen by Ismael Rafols

IMPACT project: Recovering breast cancer patients' views about the use of in-vivo biosensors to personalise radiotherapy treatment by Theresa Ikegwuonu, Gill Haddow, Joyce Tait and Ian Kunkler

Independent review on anti-microbial resistance regulation-innovation interactions and the development of anti-microbial drugs and diagnostics for human and animal diseases by Joyce Tait, Ann Bruce, James Mittra,
John Purves and Jack Scannell

Health Biotechnology to 2030 by Joyce Tait, David Wield, Ann Bruce and Joanna Chataway